 |
|
Estrogen Replacement Therapy and Mortality Among Older WomenThe Study of Osteoporotic Fractures
Jane A. Cauley, DrPH;
Dana G. Seeley, PhD;
Warren S. Browner, MD, MPH;
Kristine Ensrud, MD, MPH;
Lewis H. Kuller, MD, DrPH;
Ruth C. Lipschutz, MPH;
Stephen B. Hulley, MD, MPH
Arch Intern Med. 1997;157(19):2181-2187.
Abstract
| |
Background
Most previous studies of estrogen replacement therapy (ERT) and mortality have focused on younger women. Recently, it has been suggested that the effect of ERT on mortality may represent a "healthyuser" effect, ie, those with healthier lifestyles having a greater likelihood of receiving ERT.
Methods
Nine thousand seven hundred four women, 65 years or older, participated; 1258 (14.1%) reported current use of ERT for at least 1 year at entry. During an average follow-up of 6.0 years, 1054 women (11.8%) died.
Results
After adjusting for multiple variables, mortality rate was lower among current (relative risk [RR], 0.69; 95% confidence interval [CI], 0.54-0.87) and past users (RR, 0.79; 95% CI, 0.66-0.95), mainly due to reductions in deaths due to cardiovascular disease. The protective effect of ERT was greatest among women younger than 75 years (RR, 0.55; 95% CI, 0.40-0.76) compared with women from 75 to 84 years of age (RR, 0.93; 95% CI, 0.62-1.41) and 85 years or older (RR, 1.33; 95% CI, 0.43-4.12). The RR for overall mortality was 0.95 (95% CI, 0.68-1.32) among short-term users (1-9 years) compared with 0.55 (95% CI, 0.40-0.75) among long-term users ( 10 years). Deaths considered unrelated to ERT tended also to be reduced in current users younger than 75 years (RR, 0.72; 95% CI, 0.49-1.06) and current long-term users (RR, 0.75; 95% CI, 0.51-1.10).
Conclusions
Estrogen replacement therapy is associated with lower overall mortality rates and reduced deaths due to cardiovascular disease. Women using ERT had healthier lifestyles, and the risk for death thought to be unrelated to ERT also tended to be lower in ERT users, suggesting in part a healthy-user effect.
Arch Intern Med. 1997;157:2181-2187
Author Affiliations
From the Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pa (Drs Cauley and Kuller); the Department of Epidemiology and Biostatistics, University of California, San Francisco (Drs Seeley, Browner, and Hulley and Ms Lipschutz), and the General Internal Medicine Section, Department of Medicine, Veterans Affairs Medical Center (Dr Browner), San Francisco, Calif; and the Section of General Internal Medicine, Department of Medicine, Veterans Affairs Medical Center, and the Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis (Dr Ensrud).
Footnotes
Investigators and centers participating in the Study of Osteoporotic Fractures Research Group are given in the box on page 2186.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Postmenopausal hormone replacement therapy for primary prevention of cardiovascular and cerebrovascular disease: Recommendation statement from the Canadian Task Force on Preventive Health Care
Canadian Task Force on Preventive Health Care
CMAJ 2004;170:1388-1389.
FULL TEXT
Evaluating Medication Effects Outside of Clinical Trials: New-User Designs
Ray
Am J Epidemiol 2003;158:915-920.
ABSTRACT
| FULL TEXT
Relationship of Changes in Physical Activity and Mortality Among Older Women
Gregg et al.
JAMA 2003;289:2379-2386.
ABSTRACT
| FULL TEXT
Osteoporosis and Fractures in Postmenopausal Women Using Estrogen
Nelson et al.
Arch Intern Med 2002;162:2278-2284.
ABSTRACT
| FULL TEXT
Postmenopausal Hormone Replacement Therapy: Scientific Review
Nelson et al.
JAMA 2002;288:872-881.
ABSTRACT
| FULL TEXT
Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease
Humphrey et al.
ANN INTERN MED 2002;137:273-284.
ABSTRACT
| FULL TEXT
Ligand-Selective Interactions of ER Detected in Living Cells by Fluorescence Resonance Energy Transfer
Weatherman et al.
Mol. Endocrinol. 2002;16:487-496.
ABSTRACT
| FULL TEXT
Hormone Replacement Therapy, Insulin Sensitivity, and Abdominal Obesity in Postmenopausal Women
Ryan et al.
Diabetes Care 2002;25:127-133.
ABSTRACT
| FULL TEXT
Does Estrogen Adequately Protect Postmenopausal Women Against Osteoporosis: An Iconoclastic Perspective
Orwoll and Nelson
J. Clin. Endocrinol. Metab. 1999;84:1872-1874.
FULL TEXT
Toward an Understanding of Frailty
Hamerman
ANN INTERN MED 1999;130:945-950.
FULL TEXT
Fortnightly review: Hormone replacement therapy
Barrett-Connor
BMJ 1998;317:457-461.
FULL TEXT
Estrogen and Mortality in Older Women
JWatch Women's Health 1997;1997:18-18.
FULL TEXT
Coming of Age
Boyer
Arch Intern Med 1997;157:2173-2173.
ABSTRACT
|
